001     894460
005     20230303201752.0
024 7 _ |a 10.1002/biot.202100043
|2 doi
024 7 _ |a 1860-6768
|2 ISSN
024 7 _ |a 1860-7314
|2 ISSN
024 7 _ |a 2128/28622
|2 Handle
024 7 _ |a 34089621
|2 pmid
024 7 _ |a WOS:000662896100001
|2 WOS
037 _ _ |a FZJ-2021-03236
082 _ _ |a 570
100 1 _ |a Tenhaef, Niklas
|0 P:(DE-Juel1)168172
|b 0
245 _ _ |a Microaerobic growth‐decoupled production of α‐ketoglutarate and succinate from xylose in a one‐pot process using Corynebacterium glutamicum
260 _ _ |a Weinheim
|c 2021
|b Wiley-VCH
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1631518810_22188
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Biotechnologie 1
520 _ _ |a BackgroundLignocellulosic biomass is the most abundant raw material on earth. Its efficient use for novel bio-based materials is essential for an emerging bioeconomy. Possible building blocks for such materials are the key TCA-cycle intermediates α-ketoglutarate and succinate. These organic acids have a wide range of potential applications, particularly in use as monomers for established or novel biopolymers. Recently, Corynebacterium glutamicum was successfully engineered and evolved towards an improved utilization of d-xylose via the Weimberg pathway, yielding the strain WMB2evo. The Weimberg pathway enables a carbon-efficient C5-to-C5 conversion of d-xylose to α-ketoglutarate and a shortcut route to succinate as co-product in a one-pot process.Methods and ResultsC. glutamicum WMB2evo was grown under dynamic microaerobic conditions on d-xylose, leading to the formation of comparably high amounts of succinate and only small amounts of α-ketoglutarate. Subsequent carbon isotope labeling experiments verified the targeted production route for both products in C. glutamicum WMB2evo. Fed-batch process development was initiated and the effect of oxygen supply and feeding strategy for a growth-decoupled co-production of α-ketoglutarate and succinate were studied in detail. The finally established fed-batch production process resulted in the formation of 78.4 mmol L−1 (11.45 g L−1) α-ketoglutarate and 96.2 mmol L−1 (11.36 g L−1) succinate.ConclusionThe developed one-pot process represents a promising approach for the combined supply of bio-based α-ketoglutarate and succinate. Future work will focus on tailor-made down-stream processing of both organic acids from the fermentation broth to enable their application as building blocks in chemical syntheses. Alternatively, direct conversion of one or both acids via whole-cell or cell-free enzymatic approaches can be envisioned; thus, extending the network of value chains starting from cheap and renewable d-xylose.AbstractThe Weimberg pathway enables a carbon-efficient C5-to-C5 conversion of xylose to α-ketoglutarate and a shortcut route to succinate as established platform chemical. In this study, we employed the recently engineered and evolved strain C. glutamicum WMB2evo to establish a one-pot cultivation process for co-production of α-ketoglutarate and succinate from xylose.
536 _ _ |a 2171 - Biological and environmental resources for sustainable use (POF4-217)
|0 G:(DE-HGF)POF4-2171
|c POF4-217
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Kappelmann, Jannick
|0 P:(DE-Juel1)161539
|b 1
700 1 _ |a Eich, Arabel
|0 P:(DE-Juel1)173876
|b 2
700 1 _ |a Weiske, Marc
|0 P:(DE-Juel1)173753
|b 3
700 1 _ |a Brieß, Lisette
|0 P:(DE-Juel1)176823
|b 4
700 1 _ |a Brüsseler, Christian
|0 P:(DE-Juel1)166290
|b 5
700 1 _ |a Marienhagen, Jan
|0 P:(DE-Juel1)144031
|b 6
700 1 _ |a Wiechert, Wolfgang
|0 P:(DE-Juel1)129076
|b 7
700 1 _ |a Noack, Stephan
|0 P:(DE-Juel1)129050
|b 8
|e Corresponding author
773 _ _ |a 10.1002/biot.202100043
|g p. 2100043 -
|0 PERI:(DE-600)2214038-4
|n 9
|p 2100043 -
|t Biotechnology journal
|v 16
|y 2021
|x 1860-7314
856 4 _ |u https://juser.fz-juelich.de/record/894460/files/Tenhaef%20et%20al%202021%20Biotechnol%20J%20online.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:894460
|p openaire
|p open_access
|p OpenAPC_DEAL
|p driver
|p VDB
|p openCost
|p dnbdelivery
|q OpenAPC
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)168172
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)144031
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 7
|6 P:(DE-Juel1)129076
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)129050
913 1 _ |a DE-HGF
|b Forschungsbereich Erde und Umwelt
|l Erde im Wandel – Unsere Zukunft nachhaltig gestalten
|1 G:(DE-HGF)POF4-210
|0 G:(DE-HGF)POF4-217
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-200
|4 G:(DE-HGF)POF
|v Für eine nachhaltige Bio-Ökonomie – von Ressourcen zu Produkten
|9 G:(DE-HGF)POF4-2171
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-04
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BIOTECHNOL J : 2019
|d 2021-02-04
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-02-04
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-04
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-02-04
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-04
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-04
915 p c |a APC keys set
|2 APC
|0 PC:(DE-HGF)0000
915 p c |a Local Funding
|2 APC
|0 PC:(DE-HGF)0001
915 p c |a DFG OA Publikationskosten
|2 APC
|0 PC:(DE-HGF)0002
915 p c |a DEAL: Wiley 2019
|2 APC
|0 PC:(DE-HGF)0120
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBG-1-20101118
|k IBG-1
|l Biotechnologie
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a APC


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21